Sort
25,944 grants matching “neurodegeneration”
Toxicant-induced synaptic dysfunction and neurotoxicity in Parkinson disease
$238,569Kim Tieu · Florida International University · R01 · FY2017 · ES
Biomarker discovery for juvenile neuronal ceroid lipofuscinosis
$238,500David Edward Sleat · Rbhs-Robert Wood Johnson Medical School · R21 · FY2016 · NS
The epichaperome: A novel therapeutic target for traumatic brain injury
$238,500C Edward Dixon · University Of Pittsburgh At Pittsburgh · R21 · FY2024 · NS
PAPP-A as a Potential Target in Alzheimer's Disease
$238,500Cheryl A Conover · Mayo Clinic Rochester · R21 · FY2024 · AG
Immunosuppression in humans with AD
$238,500Carol A Colton · Duke University · R21 · FY2017 · AG
Novel 3D brain tissue-based screening assay for targeting microglia in CNS neurodegeneration
$238,500Donald C Lo · Duke University · R21 · FY2016 · NS
Neuroinflammation induced by mild viral encephalitis during young adulthood accelerates tauopathy-mediated neurodegeneration later in life.
$238,500Charles Lee Howe · Mayo Clinic Rochester · R21 · FY2018 · NS
Neuroprotective function of microglial TREM2 in TDP43-related neurodegeneration
$238,500Long-Jun Wu · Mayo Clinic Rochester · R21 · FY2020 · AG
Nanotechnology for Amyotrophic Lateral Sclerosis
$238,500Kenneth Hensley · University Of Toledo Health Sci Campus · R21 · FY2009 · NS
Glia Exclusive Gene Therapy
$238,500Or Shemesh · University Of Pittsburgh At Pittsburgh · R21 · FY2023 · EB
Brain organoid modeling of Gaucher disease for identification of pathogenic pathways and therapy development
$238,500Ying Sun · Cincinnati Childrens Hosp Med Ctr · R21 · FY2020 · HD
Regulating mtDNA and mtRNA dynamics by the mitochondrial AAA+ Lon protease
$238,500Carolyn K Suzuki · Rbhs-New Jersey Medical School · R21 · FY2016 · HD
Immune Contribution to Brain Atrophy
$238,500Aaron J Johnson · Mayo Clinic Rochester · R21 · FY2016 · NS
The Role of Sting in Lysosomal Storage Disorder
$238,468Nan Yan · Ut Southwestern Medical Center · R21 · FY2024 · AI
Effect of enriched environment on ALS neurodegeneration
$238,450Columbia University Health Sciences · R21 · FY2004 · ES
Research Training in Age-Related Cognitive Disorders
$238,423Marilyn S Albert · Johns Hopkins University · T32 · FY2016 · AG
Gender-Specific Treatment of Pediatric Cardiac Arrest
$238,331Robert S. Clark · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · HD
Gender-Specific Treatment of Pediatric Cardiac Arrest
$238,331Robert S. Clark · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · HD
NEUROBIOLOGY
$238,315University Of California San Diego · P01 · FY2005 · DA
New PET imaging agent for monitoring treatment response in Alzheimer's disease
$238,232Michelle Louise James · Stanford University · R21 · FY2015 · AG
PHOSPHORYLATION AND REGULATION OF DOPAMINE TRANSPORTER
$238,184University Of North Dakota · R01 · FY2000 · DA
TDP-43 acetylation as a pathogenic modification in ALS & related proteinopathies
$238,169Todd Jonathan Cohen · Univ Of North Carolina Chapel Hill · R00 · FY2016 · NS
Generation and Characterization of Novel Drosophila Models of TDP-43 Toxicity
$238,114Fen-Biao Gao · Univ Of Massachusetts Med Sch Worcester · R21 · FY2013 · NS
CYSTATIN C INHIBITOR OF NEURONAL ABNORMALITIES IN AD
$238,028Nathan S. Kline Institute For Psych Res · P01 · FY2005 · AG
Mis-regulation of Mitochondrial Motility in Parkinsonian Neurodegeneration
$238,028Xinnan Wang · Stanford University · R00 · FY2013 · NS